ISSN: 0378-5122
Journal Home
Journal Guideline
Maturitas Q1 Unclaimed
Maturitas is a journal indexed in SJR in Biochemistry, Genetics and Molecular Biology (miscellaneous) and Obstetrics and Gynecology with an H index of 127. It has a price of 3015 €. It has an SJR impact factor of 1,28 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,28.
Maturitas focuses its scope in these topics and keywords: health, women, cancer, study, therapy, older, endometrial, postmenopausal, walking, ovarian, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
3015 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,28
SJR Impact factor127
H Index141
Total Docs (Last Year)434
Total Docs (3 years)5044
Total Refs2008
Total Cites (3 years)376
Citable Docs (3 years)3.94
Cites/Doc (2 years)35.77
Ref/DocOther journals with similar parameters
Nature Protocols Q1
Annals of the Rheumatic Diseases Q1
Developmental Cell Q1
EMBO Journal Q1
Annual Review of Medicine Q1
Compare this journals
Aims and Scope
Best articles by citations
Associated factors to psychiatric morbidity in postmenopausal phases
View moreUse of hormone replacement therapy: women's representations of menopause and beauty care practices
View moreP201 Laparoscopic colpourethrocystopexi in postmenopausal women
View moreEstrogen with interrupted progestin HRT: a review of experimental and clinical studies
View moreConceptualizing menopause and midlife: Chinese American and Chinese women in the US
View moreP223 Endometrial effects during long-term hormonal replacement therapy
View moreThe influence of oestrogen replacement on faecal incontinence in postmenopausal women
View moreP255 Long-term effects of different hormone replacement therapy regimens on the endometrium
View moreDeclining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland
View moreP260 The effect of endometrium in postmenopausal women receiving hormone replacement therapy alternative to oral therapy
View moreP267 A double-blind, placebo-controlled crossover study to determine the effects of a new 17B oestradiol transdermal matrix patch on climacteric symptoms in hysterectomised postmenopausal women
View moreP007 Effect of medrogestone in the maintenance of bone density of surgically-menopausic women using oral and transdermal-estrogen substitutive therapy
View moreP274 Oral testosterone - A viable alternative to injection or implant
View moreA double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women
View moreInterpretation of elevated FSH in the regular menstrual cycle
View moreMicturition complaints in postmenopausal women treated with continuously combined hormone replacement therapy: a prospective study
View moreOral alendronate induces progressive increases in bone mass of the spine, hip and total body over 3 years in postmenopausal women with osteoporosis
View moreDrug concentration effect relationship of estradiol from two matrix transdermal delivery systems: Menorest® and Climara®
View moreP034 Bone mass density and mechanical properties of forearms of women in peri and postmenopausal period affected by Colles fractures
View moreA07 The role of menopause clinics
View moreP041 Tea consumption and bone mineral density in postmenopausal women
View moreEffects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures
View moreP050 Hormone replacement therapy (HRT): A comparison of informed decision making and patient satisfaction in a traditional office visit versus a group visit
View moreP058 What is involved in co-ordinating and implementing a multicentre hormone replacement therapy (HRT) clinical trial?-An Australian perspective
View more
Comments